Germline cells derived from mesenchymal stem cells, with the focus on Wharton's jelly

Previous attempts have indicated that mesenchymal stem cells (MSCs) are a valuable source and candidate and new approach for tissue engineering and reproductive medicine. MSCs have this potential to be induced and differentiated in an appropriate in vivo and in vitro condition toward various cell lineages and then they can be applied in cell therapies and clinical applications. During recent two decades, various sources have demonstrated they are a great source for MSCs, including bone marrow, the human umbilical cord as well as Whartonu0027s jelly. Due to discarding after birth, easily accessible cells and less ethical concerns, these cells have attracted more and more scientistsu0027 attention. Infertility and reproduction diseases have provided special opportunity to examine the efficiency of MSCs in this kind of application. Based on recent investigations, MSCs embedded in Whartonu0027s jelly tissue are more appealing for cell therapies, especially in infertility treatment purposes. So, differentiation of MSCs embedded in Whartonu0027s jelly tissue into germ layer cells for cell-based therapy purposes is now under intensive study.